PT Indofarma Tbk Class B(ID:INAF)
ID:INAF
PT Indofarma Tbk Class B financials statements
PT Indofarma Tbk Class B (INAF) Ratios
PT Indofarma Tbk Class B Ratios
ID:INAF's free cash flow for Q4 2025 was Rp-30.61B. For the 2025 fiscal year, ID:INAF's free cash flow was increased by Rp0.00 and operating cash flow was Rp-30.61B. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Jun 24 | Mar 23 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.19 | 0.09 | 0.16 | 0.88 | 1.35 |
| Quick Ratio | 0.05 | 0.07 | 0.11 | 0.63 | 1.03 |
| Cash Ratio | 0.01 | 0.01 | 0.01 | 0.27 | 0.36 |
| Solvency Ratio | -0.05 | -0.18 | -0.44 | -0.27 | -0.00 |
| Operating Cash Flow Ratio | -0.33 | -0.01 | -0.15 | -0.08 | 0.09 |
| Short-Term Operating Cash Flow Coverage | -0.86 | -0.04 | -0.47 | -0.39 | 0.46 |
| Net Current Asset Value | Rp -1.12T | Rp -1.63T | Rp -1.36T | Rp -584.07B | Rp -92.18B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 1.31 | 1.20 | 0.92 | 0.41 | 0.30 |
| Debt-to-Equity Ratio | -0.99 | -0.65 | -0.87 | 7.26 | 1.19 |
| Debt-to-Capital Ratio | -105.18 | -1.82 | -6.85 | 0.88 | 0.54 |
| Long-Term Debt-to-Capital Ratio | -1.81 | -0.23 | -0.58 | 0.83 | 0.44 |
| Financial Leverage Ratio | -0.76 | -0.54 | -0.94 | 17.76 | 3.96 |
| Debt Service Coverage Ratio | -0.73 | -0.52 | -1.36 | -1.69 | 0.16 |
| Interest Coverage Ratio | -6.84 | -8.45 | -9.98 | -12.59 | 1.21 |
| Debt to Market Cap | 1.79 | 1.89 | 0.39 | 0.17 | 0.09 |
| Interest Debt Per Share | 235.77 | 248.12 | 245.94 | 214.66 | 209.02 |
| Net Debt to EBITDA | -3.56 | -3.11 | -1.18 | -0.75 | 2.58 |
| Profitability Margins | |||||
| Gross Profit Margin | -12.89% | -17.83% | -32.84% | -9.62% | 15.56% |
| EBIT Margin | -137.39% | -120.61% | -116.31% | -44.68% | 1.79% |
| EBITDA Margin | -128.70% | -111.32% | -111.04% | -41.88% | 2.99% |
| Operating Profit Margin | -137.39% | -120.60% | -115.25% | -41.91% | 1.79% |
| Pretax Profit Margin | -47.15% | -134.88% | -127.87% | -45.24% | 0.30% |
| Net Profit Margin | -51.46% | -158.99% | -137.70% | -37.45% | -1.29% |
| Continuous Operations Profit Margin | -51.46% | -158.99% | -137.70% | -40.00% | -1.29% |
| Net Income Per EBT | 109.14% | 117.88% | 107.69% | 82.79% | -428.25% |
| EBT Per EBIT | 34.32% | 111.84% | 110.94% | 107.93% | 16.88% |
| Return on Assets (ROA) | -14.55% | -54.11% | -94.89% | -27.93% | -1.87% |
| Return on Equity (ROE) | 11.03% | 29.24% | 89.66% | -496.17% | -7.39% |
| Return on Capital Employed (ROCE) | 215.40% | 28.54% | 128.05% | -87.39% | 5.38% |
| Return on Invested Capital (ROIC) | -140.11% | 69.41% | 915.21% | -53.36% | -18.96% |
| Return on Tangible Assets | -14.60% | -54.36% | -95.20% | -28.07% | -1.88% |
| Earnings Yield | -19.97% | -85.65% | -40.11% | -12.02% | -0.54% |
| Efficiency Ratios | |||||
| Receivables Turnover | 8.11 | 4.48 | 7.97 | -21.76 | 6.96 |
| Payables Turnover | 9.84 | 0.50 | 1.42 | 2.26 | 4.31 |
| Inventory Turnover | 2.02 | 7.44 | 10.55 | 5.14 | 7.34 |
| Fixed Asset Turnover | 0.45 | 0.55 | 1.28 | 2.47 | 6.08 |
| Asset Turnover | 0.28 | 0.34 | 0.69 | 0.75 | 1.44 |
| Working Capital Turnover Ratio | -0.16 | -0.17 | -0.91 | 9.36 | 8.74 |
| Cash Conversion Cycle | 188.40 | -604.64 | -176.05 | -107.12 | 17.46 |
| Days of Sales Outstanding | 45.03 | 81.40 | 45.80 | -16.78 | 52.45 |
| Days of Inventory Outstanding | 180.47 | 49.08 | 34.60 | 71.00 | 49.71 |
| Days of Payables Outstanding | 37.10 | 735.12 | 256.44 | 161.34 | 84.71 |
| Operating Cycle | 225.50 | 130.48 | 80.40 | 54.22 | 102.17 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -67.72 | -6.99 | -61.34 | -24.50 | 29.97 |
| Free Cash Flow Per Share | -67.72 | -7.12 | -62.87 | -28.85 | 23.07 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | -50.86 | -40.12 | -5.64 | 4.34 |
| Capital Expenditure Coverage Ratio | 0.00 | -50.86 | -40.12 | -5.64 | 4.34 |
| Operating Cash Flow Coverage Ratio | -0.30 | -0.03 | -0.27 | -0.12 | 0.15 |
| Operating Cash Flow to Sales Ratio | -1.38 | -0.10 | -0.36 | -0.07 | 0.03 |
| Free Cash Flow Yield | -53.75% | -5.65% | -10.84% | -2.51% | 1.03% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -5.01 | -1.17 | -2.49 | -8.32 | -183.99 |
| Price-to-Sales (P/S) Ratio | 2.58 | 1.86 | 3.43 | 3.12 | 2.38 |
| Price-to-Book (P/B) Ratio | -0.55 | -0.34 | -2.24 | 41.27 | 13.60 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -1.86 | -17.69 | -9.23 | -39.86 | 96.67 |
| Price-to-Operating Cash Flow Ratio | -1.86 | -18.03 | -9.46 | -46.93 | 74.40 |
| Price-to-Earnings Growth (PEG) Ratio | 0.07 | 0.02 | -0.04 | -0.01 | 0.00 |
| Enterprise Value Multiple | -5.56 | -4.78 | -4.27 | -8.19 | 82.32 |
| Enterprise Value | 1.09T | 1.12T | 2.48T | 3.92T | 7.14T |
| EV to EBITDA | -5.56 | -4.78 | -4.27 | -8.19 | 82.32 |
| EV to Sales | 7.16 | 5.32 | 4.74 | 3.43 | 2.46 |
| EV to Free Cash Flow | -5.17 | -50.70 | -12.74 | -43.86 | 99.80 |
| EV to Operating Cash Flow | -5.17 | -51.69 | -13.06 | -51.64 | 76.81 |
| Tangible Book Value Per Share | -228.68 | -370.06 | -260.27 | 25.43 | 160.23 |
| Shareholders’ Equity Per Share | -228.10 | -369.13 | -259.46 | 27.86 | 164.01 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.09 | -0.18 | -0.08 | 0.17 | 5.28 |
| Revenue Per Share | 48.90 | 67.88 | 168.94 | 369.15 | 936.35 |
| Net Income Per Share | -25.16 | -107.93 | -232.63 | -138.25 | -12.12 |
| Tax Burden | 1.09 | 1.18 | 1.08 | 0.83 | -4.28 |
| Interest Burden | 0.34 | 1.12 | 1.10 | 1.01 | 0.17 |
| Research & Development to Revenue | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.67 | 0.33 | 0.41 | 0.08 | 0.03 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 2.69 | 0.06 | 0.26 | 0.17 | -2.47 |
Currency in IDR
